Telehealth in Family Medicine

Telehealth has reshaped how family medicine physicians deliver care by enabling clinical encounters, chronic disease monitoring, and behavioral health support without requiring in-person presence. This page covers the definition and regulatory scope of telehealth in family medicine, the technical and clinical mechanisms that underpin it, the conditions and scenarios where it is most commonly applied, and the decision boundaries that determine when in-person care is necessary. Understanding these distinctions matters because telehealth reimbursement, licensure requirements, and clinical appropriateness are all governed by overlapping federal and state frameworks.


Definition and scope

Telehealth in family medicine refers to the delivery of health-related services and information via electronic information and telecommunication technologies. The Health Resources and Services Administration (HRSA) distinguishes telehealth broadly from the narrower term telemedicine, with telemedicine referring specifically to remote clinical services, while telehealth also encompasses provider training, administrative meetings, and patient education delivered electronically.

Within family medicine, telehealth spans four primary modalities recognized by the Centers for Medicare & Medicaid Services (CMS):

  1. Synchronous video visits — real-time audiovisual encounters between patient and clinician
  2. Telephone-only encounters — audio-only visits, subject to separate billing rules under Medicare
  3. Asynchronous (store-and-forward) — transmission of recorded health data, images, or patient-reported information reviewed by a clinician at a later time
  4. Remote Patient Monitoring (RPM) — continuous or periodic collection of physiologic data (blood pressure, glucose, weight) via connected devices, transmitted to the care team

The regulatory landscape for telehealth intersects with the broader framework described at /regulatory-context-for-family-medicine, including Medicare conditions of participation, HIPAA requirements, and state medical practice acts. As of 2023, CMS telehealth coverage for Medicare beneficiaries was governed under expansions originally authorized by the Consolidated Appropriations Act of 2023 (CMS Telehealth Services Fact Sheet).


How it works

A telehealth encounter in family medicine follows a structured clinical workflow that mirrors in-person visits in key respects while introducing distinct technical and regulatory requirements.

The core process involves five phases:

  1. Scheduling and consent — The patient schedules a telehealth appointment through a patient portal, phone, or app. Informed consent for telehealth is required in most states and must be documented in the medical record, per guidance from the American Academy of Family Physicians (AAFP).

  2. Technology verification — The physician's practice must use a platform compliant with HIPAA's Security Rule (45 CFR Part 164). CMS temporarily permitted use of non-HIPAA-compliant platforms during the COVID-19 public health emergency, but standard practice requires encrypted, access-controlled video tools.

  3. Clinical encounter — The physician conducts the history, reviews available data (labs, vitals from RPM, prior records), and performs whatever limited physical assessment is feasible. A 2022 AAFP survey found that 83 percent of family physicians reported using telehealth in their practice, up from under 20 percent before 2020 (AAFP 2022 Practice Profile).

  4. Documentation — The encounter is documented in the EHR following standard evaluation and management (E/M) coding guidelines. CMS billing for synchronous telehealth uses Place of Service code 02 (telehealth other than patient's home) or 10 (patient's home).

  5. Prescribing and follow-up — Prescriptions, referrals, or lab orders are issued electronically. Controlled substance prescribing via telehealth is subject to the Ryan Haight Online Pharmacy Consumer Protection Act (21 U.S.C. § 829) and DEA regulations, which historically required at least one in-person encounter before prescribing Schedule II–V substances via telemedicine, though DEA proposed rule modifications in 2023.


Common scenarios

Telehealth is not uniformly applicable across all family medicine services. The following conditions and encounter types have the strongest evidence base and policy support for telehealth delivery:


Decision boundaries

Not all clinical needs are appropriate for telehealth delivery. Family medicine physicians apply a structured set of clinical and regulatory criteria to determine when an in-person encounter is required.

Telehealth is generally not appropriate when:

Telehealth vs. in-person: a structural comparison

Factor Telehealth In-Person
Physical exam capability Limited (visual only, patient self-report) Full clinical exam
Geographic access High — eliminates travel barrier Requires patient transport
Controlled substance prescribing Restricted under DEA Ryan Haight Act No additional restriction
HIPAA compliance requirement Required (45 CFR Part 164) Required
Billing modifiers required Yes (POS 02 or 10, modifier 95 or GT) Standard E/M codes
RPM integration High compatibility Lower integration in real-time

The Office for Civil Rights (OCR) at HHS maintains specific guidance on HIPAA compliance for telehealth technologies, which family medicine practices must apply when selecting platforms and configuring access controls.

State licensure presents an additional boundary: a physician must generally hold a medical license in the state where the patient is physically located at the time of the encounter. The Interstate Medical Licensure Compact (IMLC), administered by the IMLC Commission, allows expedited licensure in 37 participating states as of 2023, reducing but not eliminating this barrier for multi-state telehealth practice.


References


The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)